NCT06953921 Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
| NCT ID | NCT06953921 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Hepatic Encephalopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-12 |
| Primary Completion | 2025-09-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-12 with a primary completion date of 2025-09-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.
Eligibility Criteria
Inclusion Criteria: * patients aged \>18 years. * Confirmed chronic liver disease (by imaging , * liver function tests , and clinical history). * Diagnosed with hepatic encephalopathy based on clinical criteria. * Patients able to provide informed consent. Exclusion Criteria: * Patients age less than 18 years old * Acute liver failure. * Chronic renal failure on dialysis. * Pregnant women. * Patients with active malignancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06953921 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hepatic Encephalopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06953921 currently recruiting?
Yes, NCT06953921 is actively recruiting participants. Contact the research team at kerolos_latief_post@med.sohag.edu.eg for enrollment information.
Where is the NCT06953921 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06953921 clinical trial?
NCT06953921 is sponsored by Sohag University. The trial plans to enroll 100 participants.